C.A. Anderson
Papers
3
Total Citations
16
H-Index
3
About
C.A. Anderson is a pioneering structural biologist and medicinal chemist whose work is revolutionizing fragment-based drug discovery. Their research centers on overcoming the critical bottleneck in this field: efficiently progressing weakly binding fragment hits into potent lead compounds. Anderson’s major contribution is the development of **Binding-Site Purification of Actives (B-SPA)**, a groundbreaking methodology that integrates multi-step array synthesis with high-throughput crystallography. This approach, detailed in their most-cited 2025 paper (9 citations), enables the rapid, large-scale exploration of chemical space directly within the protein binding site, bypassing traditional, time-consuming purification steps. Complementing this, their 2023 work demonstrated a low-cost, robotics-driven workflow for high-throughput crystallography, making structural data collection on crude reaction mixtures both accessible and efficient. With combined citations exceeding 15, Anderson’s innovations are directly addressing a long-standing “dormant” potential in fragment approaches, offering a credible and scalable path to drug leads. Their work stands as a transformative achievement, promising to accelerate the discovery of new therapeutics by turning fragment screening into a truly high-throughput progression engine.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3